Physitrack PLC — Transactions under Share Buy-back Programme
Physitrack PLC (“Physitrack” or the “Company”) announces that, in connection with the share buy-back programme announced on 21 July 2026, the Company has repurchased its own ordinary shares during the period 9 – 13 November 2026, as set out below.
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 9 – 13 November 2026 | 4,000 | 11.1413 | 44,565.04 | 80,437 | 16,260,766 | 0.49% |
Individual transactions
| Date | Quantity | Average price (SEK) |
| 9 November 2026 | 800 | 10.8188 |
| 10 November 2026 | 800 | 11.3000 |
| 11 November 2026 | 800 | 11.1375 |
| 12 November 2026 | 800 | 11.3000 |
| 13 November 2026 | 800 | 11.1500 |
The share buy-back is carried out within the safe harbour under Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052. The purpose of the programme is to meet the Company's obligations under its employee share plans. The transactions are executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer: | Physitrack PLC; LEI 213800PC4QYNWHPCP774 |
| 2. Instrument/ISIN: | Ordinary shares / GB00BYX22590 |
| 3. Trading venue: | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency: | SEK |
| 5. Purpose: | To meet the Company's obligations under its employee share plans, permitted under Article 5(2) of MAR |
| 6. Executing broker: | Pareto Securities, acting on a non-discretionary mandate |
This disclosure is made in accordance with Article 5(3) of MAR and Commission Delegated Regulation (EU) 2016/1052.